PATENT CLAIM ANALYSIS

Application Number: 15989641
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "001000"]

Abstract:
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form, can be used to treat or alleviate pain or related conditions, such as arthritis.

Claim (Index 9):
The method of  claim 1 , wherein the oral dosage form is orally administered about weekly.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15623274', '15801049', '15604394', '15386858', '15599319']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8307086443491642
- 35 USC 102 Novelty (BERT): 0.6059642410592929
- Combined Prediction Score: 0.8082342040201771
- Mean Citation Score: 627.996934
- Max Citation Score: 628.693
- Similarity Product: 436.1157625507116

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test